by abrinkman | June 8, 2026 | Uncategorized
Making the decision to move a loved one into assisted living is rarely easy. Most families don’t wake up one morning and decide it’s time. Instead, it often happens gradually—a missed medication here, a forgotten appointment there, a growing concern that Mom or Dad may not be as safe living alone as they once were.
If you’ve been wondering whether additional support might be needed, you’re not alone.
Signs It May Be Time to Consider Assisted Living
1. Personal Care Is Being Neglected
You may notice that your loved one is bathing less frequently, wearing the same clothes repeatedly, or struggling with grooming and hygiene. These changes can happen slowly and are often among the first signs that daily living has become more difficult.
2. Meals Are Being Skipped
Look inside the refrigerator. Is there spoiled food? Empty shelves? Expired groceries?
Many seniors find cooking increasingly difficult, which can lead to poor nutrition, weight loss, and declining health.
3. Medications Are Being Missed
Missing medications or taking them incorrectly can have serious consequences. If pill bottles are piling up, doses are being forgotten, or prescriptions aren’t being refilled on time, it may be time for additional support.
4. Falls or Mobility Challenges
Even a minor fall can significantly impact a senior’s confidence and independence. If walking has become difficult or falls are becoming more frequent, a safer environment with assistance nearby may help prevent injuries.
5. Memory Changes Are Affecting Daily Life
Occasional forgetfulness is normal. However, repeatedly forgetting important appointments, becoming confused about time or place, or getting lost in familiar surroundings may signal a more serious memory concern.
6. Caregiver Stress Is Growing
Family caregivers often put their own needs last. If you’re feeling overwhelmed, exhausted, or constantly worried, that’s an important sign too.
Seeking help isn’t giving up. It’s ensuring your loved one receives the support they need while allowing you to return to being a daughter, son, spouse, or friend.
The Goal Isn’t Less Independence—It’s More Quality of Life
Many families fear that assisted living means losing independence. In reality, the right environment often helps seniors regain confidence, social interaction, proper nutrition, and a sense of security.
At Lily’s Promise, we believe assisted living should feel like home. Our small residential homes provide personalized care in a warm, familiar setting where residents are known, valued, and treated like family.
We’re Here to Help
If you’re wondering whether now is the right time, we’d be honored to talk through your situation. Sometimes a simple conversation can provide clarity and peace of mind.
Lily’s Promise Residential Care Homes
941-926-5459
Care with Heart. Promise with Purpose.
by abrinkman | August 29, 2022 | Uncategorized
These Sand Hill Cranes come to visit several times a week. They can be seen flying into our back yard area, walking down our street or like today in our front yard.
by abrinkman | August 29, 2022 | Uncategorized
Seth Rogen and his wife, Lauren Miller, watched as her mother lost her ability to speak, feed, and dress herself, all by age 60. Now Rogen, star of the new movie The Interview, bravely tells Glamour how that changed their lives, their marriage—and their future. As told to Alex Morris.
by abrinkman | August 29, 2022 | Uncategorized
Alzheimer's could be prevented and even cured by boosting the brain's own immune response, scientists at Stanford University believe.
Researchers discovered that nerve cells die because cells which are supposed to clear the brain of bacteria, viruses and dangerous deposits, stop working.
These cells, called 'microglia' function well when people are young, but when they age, a single protein called EP2 stops them operating efficiently. (By Sarah Knapton, Science Editor) The Telegraph
Now scientists have shown that blocking the protein allows the microglia to function normally again so they can hoover up the dangerous sticky amyloid-beta plaques which damage nerve cells in Alzheimer's disease.
The researchers found that, in mice, blocking EP2 with a drug reversed memory loss and myriad other Alzheimer’s-like features in the animals.
“Microglia are the brain’s beat cops,” said Dr Katrin Andreasson, Professor of neurology and neurological sciences at Stanford University School of Medicine.
“Our experiments show that keeping them on the right track counters memory loss and preserves healthy brain physiology.”
By 2015 there will be 850,000 people with dementia in the UK, with Alzheimer's disease being the most common type. The disease kills at least 60,000 people each year.
Microglial cells make up around 10 to 15 per cent of cells in the brain. They act as a frontline defence, looking for suspicious activities and materials. When they spot trouble, they release substances that recruit other microglia to the scene which then destroy and get rid of any foreign invaders.
They also work as garbage collectors, chewing up dead cells and molecular debris strewn among living cells including clusters of amyloid-beta which aggregate as gummy deposits and break the connections between neurons, causing loss of memory and spatial awareness. These clusters are believed to play a substantial role in causing Alzheimer’s.
“The microglia are supposed to be, from the get-go, constantly clearing amyloid-beta, as well as keeping a lid on inflammation,” added Dr Andreasson. “If they lose their ability to function, things get out of control. A-beta builds up in the brain, inducing toxic inflammation.”
The scientists discovered that in young mice, the microglia kept the sticky plaques under control. But when experiments were done on older mice, the protein EP2 swung into action and stopped the microglia producing enzymes which digested the plaques.
Similarly mice which were genetically engineered not to have EP2 did not develop Alzheimer's disease, even when injected with a solution of amyloid-beta, suggesting that their cells were getting rid of the protein naturally.
And for those mice who developed Alzheimer's, blocking EP2 reversed memory decline.
Now Stanford is hoping to produce a compound which only blocks EP2 to prevent unnecessary side effects.
The study was published in the Journal of Clinical Investigation. (Article By Sarah Knapton, Science Editor) The Telegraph
